新发心力衰竭的性别特异性危险因素:PREVEND研究25年随访
基于PREVEND队列8558名参与者25年随访,共识别804例新发心衰(HFrEF 534例,HFpEF 270例)。男性HFrEF终生风险高于女性(18.1% vs 11.9%),女性HFpEF终生风险高于男性(11.5% vs 6.4%)。八项可干预危险因素在女性中归因比例更高(HFrEF 71% vs 男性60%,HFpEF 64% vs 男性46%)。
要点
- 男性HFrEF终生风险更高,女性HFpEF终生风险更高。
- 高血压和高胆固醇血症是HFrEF最强危险因素,高血压和肥胖是HFpEF最强危险因素。
- 八项可干预危险因素在女性中对新发心衰的归因比例高于男性。
核心结论
- 在欧洲社区队列中,男性HFrEF终生风险高于女性,而女性HFpEF终生风险高于男性。
- 八项直接或间接可干预危险因素显著解释了HFrEF和HFpEF的发生风险,尤其在女性中归因比例更高。
研究设计与样本
- PREVEND队列研究,8558名参与者自1997年起基线评估,随访至2022年,通过住院记录判定新发HFrEF(射血分数<50%)和HFpEF(射血分数≥50%)。
- 随访25年,共识别804例新发心衰(HFrEF 534例,HFpEF 270例);男性基线平均年龄50岁,女性47岁。
主要发现
- 心衰发病平均年龄男性72.1岁,女性74.2岁。
- 总终生心衰风险男性24.5%,女性23.3%。
- HFrEF终生风险女性低于男性(11.9% vs 18.1%),HFpEF终生风险女性高于男性(11.5% vs 6.4%)。
- 女性中71%的新发HFrEF归因于八项危险因素,男性为60%;女性中64%的新发HFpEF归因于这些因素,男性为46%。
- 男性和女性中,高血压和高胆固醇血症是HFrEF最强危险因素,高血压和肥胖是HFpEF最强危险因素。
临床怎么用
- 临床应关注性别差异:男性侧重HFrEF风险评估,女性侧重HFpEF风险评估。
- 针对高血压、高胆固醇血症、肥胖、吸烟、房颤、慢性肾病、心肌梗死和糖尿病进行综合干预,尤其在女性中可显著降低心衰风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Current estimates for the lifetime risk to develop heart failure with either a reduced (HFrEF) or preserved ejection fraction (HFpEF) and their associated risk factors are derived from two studies from the USA. The sex-specific lifetime risk and population attributable fraction of potentially modifiable risk factors for incident HFpEF and HFrEF are described in a large European community-based cohort with 25 years of follow-up. METHODS: A total of 8558 participants from the PREVEND cohort were studied at baseline from 1997 onwards and followed until 2022 for cases of new-onset HFrEF (ejection fraction < 50%) and HFpEF (ejection fraction ≥ 50%) by assessment of hospital records. RESULTS: A total of 804 cases of new-onset HF were identified (534 HFrEF and 270 HFpEF) during 25 years of follow-up. The mean age at baseline was 50 years for men and 47 years for women. The mean age at onset of HF was 72.1 years in men and 74.2 years in women. The overall lifetime risk of developing HF was 24.5% in men compared to 23.3% in women. The lifetime risk of HFrEF was lower in women compared with men (11.9% vs. 18.1%), while the lifetime risk of HFpEF was higher in women compared with men (11.5% vs. 6.4%). In women, 71% of incident HFrEF cases were attributable to eight risk factors (hypertension, hypercholesterolaemia, obesity, smoking, atrial fibrillation, chronic kidney disease, myocardial infarction, and diabetes mellitus) and 60% in men. In women, 64% of incident HFpEF cases were attributable to those risk factors, whereas this was 46% in men. More specifically, in both men and women, hypertension and hypercholesterolaemia were the strongest risk factors for HFrEF, whereas hypertension and obesity were the strongest risk factors for HFpEF. CONCLUSIONS: In this European cohort, the lifetime risk of developing HFrEF was greater in men than in women, while women were at greater risk of developing HFpEF. Eight directly and indirectly modifiable risk factors substantially accounted for the risk of developing HFrEF and HFpEF, particularly in women.
引用
- van Essen, Emmens, Tromp, et al. Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years. Eur Heart J. 2025. PMID: 39786471. doi:10.1093/eurheartj/ehae868
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。